Early-onset Parkinson's disease (EOPD) refers to that of patients who have been diagnosed or had onset of motor symptoms before age 50, accounting for 4% of Parkinson's disease patients. The PRKN and PINK1 genes, both involved in a metabolic pathway, are associated with EOPD.
To identify variants associated with EOPD, coding region of PARKIN and PINK1 genes in 112 patients and 112 healthy individuals were sequenced. Multiplex ligation-dependent probe amplification kit was used to determine EOPD patients that carried mutations in PRKN and PINK1 genes.
Three rare and three novel mutations in total of 14 variants of PARKIN and PINK1 were detected in the EOPD cohorts. Mutations of PRKN and PINK1 genes were found in five (4.4%) patients, which were four patients with compound heterozygous variants in the PRKN and one case with a homozygous mutation of the PINK1 gene. The novel mutations might reduce the stability of the PRKN and PINK1 protein molecules. The frequency of homozygous mutant genotype p.A340T of amese EOPD patients. These results might contribute to the genetic screening of EOPD in Vietnam.Nonerythropoietic erythropoietins (EPOs) are investigated for their high antioxidant properties. A new drug candidate under clinical investigation to treat brain diseases is Neuro-EPO, produced by selecting EPO isoforms with low sialic acid content. Intranasal administration allows to bypass the blood-brain barrier to get a fast and concentrated delivery to the brain. The aims of this project were to characterize Neuro-EPO with anti-doping methods used to detect conventional recombinant EPOs (isoelectric focusing [IEF] and sodium dodecyl sulfate-polyacrylamide gel electrophoresis [SDS-PAGE]) and to evaluate the window of detection of Neuro-EPO in brain and blood (plasma) after a single intranasal administration in rats. Neuro-EPO drug analyzed by IEF-PAGE presented a very basic profile completely detected only when using a 2-8 or 2-10 pH gradient instead of the conventional 2-6 pH gradient. Its profile consisted in six main bands that did not interfere with endogenous EPO profile from human or rat. After SDS-PAGE, a broad band was detected for Neuro-EPO in the same area as endogenous EPO, making Neuro-EPO identification very difficult by this approach. Therefore, IEF was the method for identification chosen after administration in rats. Neuro-EPO was clearly identified in blood 2 and 6 h after the delivery. Fainter signals were obtained between 12 and 48 h, but some characteristic very basic bands remained detectable. Surprisingly, brain extracts did not show the presence of Neuro-EPO even 2 h after administration, indicating a fast degradation or elimination from the brain to the bloodstream. This experiment indicated that detection of Neuro-EPO after intranasal delivery should be possible for a few days.HLA-B*150139 has one synonymous nucleotide change from HLA-B*15010101 at nucleotide 117 (residue 15 Proline).Severe acute respiratory syndrome-associated coronavirus-2 (SARS-CoV-2) has been identified as the pathogen causing the outbreak of coronavirus disease-2019 (COVID-19) commencing in Wuhan, China, in December 2019. Multiple reports have shown subjective loss of taste and smell as an early and hallmark symptom for COVID-19.
A retrospective study was performed in our clinical practice during July 2020 on patients positive for SARS-CoV-2 via polymerase chain reaction. All patients were categorized into 3 groups (supertasters, tasters, and nontasters) via taste sensitivity to phenylthiocarbamide, thiourea, and sodium benzoate with taste strip testing. The results of the taste strip tests were correlated with clinical course.
A total of 100 patients (mean, 51 [range, 24-82] years of age; 44 [44%] women) were assessed. We found that 21 of 100 (21%) were nontasters, 79 of 100 (79%) were tasters, and 0 of 100 (0%) were supertasters (p &lt; 0.001). Twenty-one of 21 (100%) (p &lt; 0.001) of the patients requiring inpatient admission were classified as nontasters. All 79 (100%) (p &lt; 0.001) of the patients who displayed mild to moderate symptoms not requiring admission were classified as tasters.
Our results show objective data that taste disturbance, specifically global loss of taste, appears to correlate with the clinical course specific to each individual, because 100% of the patients requiring inpatient admission were classified as nontasters.
Our results show objective data that taste disturbance, specifically global loss of taste, appears to correlate with the clinical course specific to each individual, because 100% of the patients requiring inpatient admission were classified as nontasters.The purpose of this research is to estimate the efficiency of vein viewing device on 9-12?year-old children's pain and anxiety.
The research has been designed as an experimental study including pre-and post-test and control groups. Data were collected with personal information form, facial expressions rating scale, state anxiety scale, vein viewing device and a peripheral cannula. Both groups were applied to the state anxiety scale before and after the procedure while the facial expressions rating scale was applied during the procedure.
Statistically significant difference was found between experimental and control groups regarding processing time, number of transaction attempts and facial expressions rating scale score averages. While there was no difference regarding the state anxiety scales average points of children in experimental and control groups before the procedure, a statistically significant difference was found in an advanced level regarding post-processing state anxiety levels.
Usage of vein viewing device during peripheral cannula intervention reduces children's pain and anxiety levels and shortens the durations of the initiative.
Usage of vein viewing device during peripheral cannula intervention reduces children's pain and anxiety levels and shortens the durations of the initiative.It is widely acknowledged that inadequate handovers are associated with putting patients at risk in clinical settings; however, handover practices have received little attention in other 24-hr settings such as long-stay residential care facilities.
This study aimed to explore the perceived purpose and organisational processes involved in the handover of information between shifts of staff caring for older residents in five care homes in England.
The study took an ethnographic approach to fieldwork, undertaken between February and June 2016. It consisted of observations of handovers (n=12) and interviews with managers, Registered Nurses (RNs) and care assistants (n=27) working day and night shifts. Interview transcripts and observation notes were analysed within NVivo using a matrix approach.
Handovers were highly variable in all five care homes in relation to their timings, locations, content and participants. https://www.selleckchem.com/products/pifithrin-alpha.html Managers and RNs highlighted handovers as an opportunity for risk assurance, supervision, team building, staff education and monitoring of residents' clinical status.